Preventing the weaponization of AI-designed proteins

Off Alzheimer's disease, Alzheimer’s, artificial intelligence, Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, genetics, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today, we talk about a new online marketplace to trade animal parts for research, an initiative to ensure ethics in AI-driven protein synthesis, and more.

Read the rest…

Read Original Article: Preventing the weaponization of AI-designed proteins »

About The Author